| 摘要 |
This invention features an antibody specifically binding to human IL-20 ( e.g., mAb 7E and a equivalent thereof) and its use in treating an IL-20 asso ciated inflammatory disease, such as atherosclerosis, RA, psoriasis, psoriat ic arthritis, bacteria-induced gastric ulcer, and acute renal failure.
|
